6th Edition of International Conference on Tissue Engineering and Regenerative Medicine
September 28-30 | London, UK
Immunotherapy & Immune Engineering
Understanding and manipulating immune responses is critical for successful tissue regeneration. Immunotherapy & immune engineering explores how engineered immune cells and modulatory agents enhance tissue repair, prevent graft rejection, and support integration of bioengineered constructs. Researchers are developing immune-compatible scaffolds and combining stem cell technologies with immune checkpoint modulation to achieve lasting outcomes. Engineered T cells, regulatory macrophages, and cytokine delivery systems are now being applied to modulate inflammation and direct healing. The integration of immune engineering with regenerative platforms also contributes to resolving chronic inflammation and improving scaffold longevity. Immunotherapy & immune engineering continues to evolve into a cornerstone of precision regeneration, offering targeted solutions for both autoimmune and degenerative conditions.
Kunal Mitra
Florida Tech, United States
Nagy Habib
Imperial College London, United Kingdom
Alexander Seifalian
Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Paige Derr
National Institutes of Health, United States
Aradhana Kasimsetty
National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States
Lisa Martin
University Grenoble Alpes, France
Audrey Cherblanc
Healshape SAS, FranceSubmit your abstract Today
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States